tradingkey.logo

BioLife Solutions Inc

BLFS
22.686USD
+0.256+1.14%
交易中 美东报价延迟15分钟
1.09B总市值
亏损市盈率 TTM

BioLife Solutions Inc

22.686
+0.256+1.14%

关于 BioLife Solutions Inc 公司

BioLife Solutions, Inc. is a developer and supplier of cell processing tools and services for the cell and gene therapy (CGT) market. The Company facilitates the commercialization of new therapies by supplying solutions that maintain the health and function of biologic materials during collection, development, manufacturing and distribution. Its CryoStor freeze media and HypoThermosol hypothermic storage media are optimized to preserve cells in the regenerative medicine market. Its Sexton cell processing product line includes human platelet lysates (hPL) for cell expansion. Its CellSeal cryogenic vials, which are rigid containers used in cell and gene therapy (CGT). Its CryoCase cryo-compatible transparent rigid containers are designed for closed-system fill and retrieval, and automated cell processing machines. The Company’s ThawSTAR product line is composed of a family of automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags.

BioLife Solutions Inc简介

公司代码BLFS
公司名称BioLife Solutions Inc
上市日期Nov 22, 1989
CEODe Greef (Roderick)
员工数量159
证券类型Ordinary Share
年结日Nov 22
公司地址Suite 310
城市BOTHELL
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编98021
电话14254011400
网址https://www.biolifesolutions.com/
公司代码BLFS
上市日期Nov 22, 1989
CEODe Greef (Roderick)

BioLife Solutions Inc公司高管

名称
名称/职务
职务
持股
持股变动
Dr. Aby J. Mathew, Ph.D.
Dr. Aby J. Mathew, Ph.D.
Chief Scientific Officer, Executive Vice President
Chief Scientific Officer, Executive Vice President
251.85K
-405.00%
Ms. Karen A. Foster
Ms. Karen A. Foster
Chief Quality and Operations Officer
Chief Quality and Operations Officer
149.25K
-335.00%
Mr. Troy Wichterman
Mr. Troy Wichterman
Chief Financial Officer
Chief Financial Officer
66.72K
-990.00%
Ms. Sarah Aebersold
Ms. Sarah Aebersold
Chief Human Resources Officer
Chief Human Resources Officer
48.80K
-241.00%
Mr. Joydeep Goswami
Mr. Joydeep Goswami
Independent Director
Independent Director
38.11K
-3000.00%
Sean Werner
Sean Werner
Chief Technology Officer
Chief Technology Officer
25.93K
-110.00%
Ms. Catherine (Cathy) Coste, CPA
Ms. Catherine (Cathy) Coste, CPA
Independent Director
Independent Director
5.70K
--
Mr. Roderick De Greef
Mr. Roderick De Greef
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Mr. Todd Berard
Mr. Todd Berard
Chief Commercial Officer
Chief Commercial Officer
--
--
Ms. Amy Duross
Ms. Amy Duross
Lead Independent Director
Lead Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Dr. Aby J. Mathew, Ph.D.
Dr. Aby J. Mathew, Ph.D.
Chief Scientific Officer, Executive Vice President
Chief Scientific Officer, Executive Vice President
251.85K
-405.00%
Ms. Karen A. Foster
Ms. Karen A. Foster
Chief Quality and Operations Officer
Chief Quality and Operations Officer
149.25K
-335.00%
Mr. Troy Wichterman
Mr. Troy Wichterman
Chief Financial Officer
Chief Financial Officer
66.72K
-990.00%
Ms. Sarah Aebersold
Ms. Sarah Aebersold
Chief Human Resources Officer
Chief Human Resources Officer
48.80K
-241.00%
Mr. Joydeep Goswami
Mr. Joydeep Goswami
Independent Director
Independent Director
38.11K
-3000.00%
Sean Werner
Sean Werner
Chief Technology Officer
Chief Technology Officer
25.93K
-110.00%

收入明细

单位: USD更新时间: 1月6日 周二
单位: USD更新时间: 1月6日 周二
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
业务USD
名称
营收
占比
Product Revenue-Cell processing
25.28M
90.08%
Rental Revenue- Evo and thaw
1.79M
6.38%
Product Revenue- Evo and thaw
968.00K
3.45%
Service Revenue-Evo and thaw
26.00K
0.09%
地区USD
名称
营收
占比
United States
21.33M
76.00%
Europe & Middle East & Africa (EMEA) (Region)
5.33M
19.00%
Other Countries
1.40M
5.00%
业务
地区
业务USD
名称
营收
占比
Product Revenue-Cell processing
25.28M
90.08%
Rental Revenue- Evo and thaw
1.79M
6.38%
Product Revenue- Evo and thaw
968.00K
3.45%
Service Revenue-Evo and thaw
26.00K
0.09%

股东统计

更新时间: 11月15日 周六
更新时间: 11月15日 周六
持股股东
股东类型
持股股东
持股股东
占比
Casdin Capital, LLC
12.37%
T. Rowe Price Investment Management, Inc.
10.76%
BlackRock Institutional Trust Company, N.A.
10.60%
Invesco Advisers, Inc.
7.22%
The Vanguard Group, Inc.
6.40%
其他
52.65%
持股股东
持股股东
占比
Casdin Capital, LLC
12.37%
T. Rowe Price Investment Management, Inc.
10.76%
BlackRock Institutional Trust Company, N.A.
10.60%
Invesco Advisers, Inc.
7.22%
The Vanguard Group, Inc.
6.40%
其他
52.65%
股东类型
持股股东
占比
Investment Advisor
52.44%
Investment Advisor/Hedge Fund
34.07%
Hedge Fund
15.54%
Research Firm
2.31%
Individual Investor
1.99%
Pension Fund
1.60%
Bank and Trust
0.48%
Sovereign Wealth Fund
0.08%
Insurance Company
0.03%

机构持股

更新时间: 12月8日 周一
更新时间: 12月8日 周一
报告期
机构数
持股数
持股占比
持股变动
2025Q4
408
51.30M
106.56%
-1.42M
2025Q3
418
50.60M
112.73%
+431.43K
2025Q2
417
51.14M
109.98%
+2.32M
2025Q1
412
48.78M
108.79%
-2.89M
2024Q4
397
47.68M
109.40%
+879.99K
2024Q3
391
46.15M
113.67%
-1.38M
2024Q2
371
47.55M
108.21%
+1.88M
2024Q1
363
45.48M
113.98%
-6.15M
2023Q4
383
46.46M
115.88%
+36.24K
2023Q3
386
44.68M
106.82%
+2.82M
查看更多

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
Casdin Capital, LLC
5.96M
12.37%
-750.00K
-11.18%
Oct 15, 2025
T. Rowe Price Investment Management, Inc.
4.07M
8.45%
-179.85K
-4.24%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
5.10M
10.6%
+21.37K
+0.42%
Sep 30, 2025
Invesco Advisers, Inc.
3.48M
7.22%
+21.52K
+0.62%
Sep 30, 2025
The Vanguard Group, Inc.
2.96M
6.15%
+70.25K
+2.43%
Sep 30, 2025
State Street Investment Management (US)
1.46M
3.03%
+47.61K
+3.38%
Sep 30, 2025
Fred Alger Management, LLC
1.11M
2.3%
-139.11K
-11.15%
Sep 30, 2025
Fidelity Management & Research Company LLC
1.02M
2.11%
+1.01M
+35792.97%
Sep 30, 2025
Rockefeller Capital Management
1.01M
2.1%
-16.29K
-1.59%
Sep 30, 2025
MFS Investment Management
1.10M
2.28%
-4.74K
-0.43%
Sep 30, 2025
查看更多

持股ETF

更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
Invesco S&P SmallCap Health Care ETF
0.66%
Invesco S&P SmallCap 600 Pure Growth ETF
0.62%
First Trust Multi-Manager Small Cap Opportunities ETF
0.52%
Zacks Small/Mid Cap ETF
0.41%
iShares Micro-Cap ETF
0.2%
State Street SPDR S&P 600 Small Cap Growth ETF
0.15%
First Trust Small Cap Growth AlphaDEX Fund
0.15%
Vanguard S&P Small-Cap 600 Growth Index Fund
0.14%
iShares S&P Small-Cap 600 Growth ETF
0.14%
iShares ESG Select Screened S&P Small-Cap ETF
0.09%
查看更多
Invesco S&P SmallCap Health Care ETF
占比0.66%
Invesco S&P SmallCap 600 Pure Growth ETF
占比0.62%
First Trust Multi-Manager Small Cap Opportunities ETF
占比0.52%
Zacks Small/Mid Cap ETF
占比0.41%
iShares Micro-Cap ETF
占比0.2%
State Street SPDR S&P 600 Small Cap Growth ETF
占比0.15%
First Trust Small Cap Growth AlphaDEX Fund
占比0.15%
Vanguard S&P Small-Cap 600 Growth Index Fund
占比0.14%
iShares S&P Small-Cap 600 Growth ETF
占比0.14%
iShares ESG Select Screened S&P Small-Cap ETF
占比0.09%

分红派息

近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据

拆合股

公告日期
除权除息日
类型
比率
暂无数据
公告日期
除权除息日
类型
比率
暂无数据
KeyAI